BRAF V600E and survival benefit of anti-EGFR monoclonal antibody (mAb) therapy for metastatic colorectal cancer (mCRC): A meta-analysis

Michael Sorich, Andrew Rowland, Mafalda Dias, Ross Allan McKinnon, Ganessan Kichenadasse, Michael Wiese, Christos Stelios Karapetis

    Research output: Contribution to journal › Meeting Abstract

    Fingerprint

    Dive into the research topics of 'BRAF V600E and survival benefit of anti-EGFR monoclonal antibody (mAb) therapy for metastatic colorectal cancer (mCRC): A meta-analysis'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science